Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medidata Solutions Inc    MDSO

Delayed Quote. Delayed  - 04/28 09:36:00 pm
45.1 USD   -1.16%
02:55p MEDIDATA SOLUTI : and GSK's Joint Mobile Health Initiative Wins Inau..
02:33p MEDIDATA : and GSK’s Joint Mobile Health Initiative Wins Inaug..
04/26 MEDIDATA SOLUTI : Christian Hebenstreit Joins Medidata as Managing D..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Medidata Solutions Inc : Medidata Solutions Announces Two-for-One Stock Split

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2013 | 12:31pm CEST

Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013. The stock split will be structured in the form of a stock dividend.

The record date for the stock split is December 2, 2013. Shareholders of record as of such date will receive one new share of common stock for each share that they own. The distribution of the new shares will be made on December 16, 2013, and trading on a split-adjusted basis is expected to begin on or about December 17, 2013.

Medidata had approximately 26.8 million shares of common stock outstanding as of November 7, 2013. The stock split will increase the common shares outstanding to approximately 53.6 million.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud TM brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investors:
Medidata Solutions
Hulus Alpay, 212-419-1025
halpay@mdsol.com
or
Media:
Medidata Solutions
Gail Janowitz, 212-918-1792
gjanowitz@mdsol.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on MEDIDATA SOLUTIONS INC
02:55p MEDIDATA SOLUTIONS : and GSK's Joint Mobile Health Initiative Wins Inaugural Inf..
02:33p MEDIDATA : and GSK’s Joint Mobile Health Initiative Wins Inaugural Informa..
04/26 MEDIDATA SOLUTIONS : Christian Hebenstreit Joins Medidata as Managing Director o..
04/21 MEDIDATA SOLUTIONS : beats Street 1Q forecasts
04/21 MEDIDATA SOLUTIONS, INC. : Results of Operations and Financial Condition, Financ..
04/21 MEDIDATA SOLUTIONS : Reports Record First Quarter 2016 Results
04/20 MEDIDATA SOLUTIONS : Bristol-Myers Squibb Selects Medidata Clinical Cloud® to Dr..
04/12 MEDIDATA SOLUTIONS : and Tufts Center for the Study of Drug Development Publish ..
04/07 MEDIDATA SOLUTIONS : Schedules First Quarter Earnings Conference Call for April ..
04/04 MEDIDATA SOLUTIONS : Acquires Intelemage®, a Global Leader in Managing and Trans..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials